Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It seems to me that

When you empty your treasury in the form of a dividend so u have no available captial to purchase your own shares or acquire a company, this is mismanagment at its best. must we go broke or drop to .05 before u will begin to examine the actions of management for what they are.....the result may not have been intended-----but the result is their decision has damaged the share price. Award the BOD options for this? Just where do u draw the line with management? Please point out where they have actually done something that has benefited the sharehholder? can the entire group imo.

teremoto

Share
New Message
Please login to post a reply